Jagged1 Activators are an array of chemical compounds that indirectly enhance the functional activity of Jagged1 through a variety of signaling pathways. For instance, the gamma-secretase inhibitor DAPT prevents the cleavage of Notch receptors, leading to an increased presence of membrane-bound Jagged1, which in turn facilitates more effective Notch pathway activation. Similarly, the Smoothened Agonist (SAG) indirectly bolsters Jagged1 activity by activating the Hedgehog signaling pathway, which may enhance the crosstalk with Notch signaling. Ionomycin, by elevating intracellular calcium, and PMA through PKC activation, both contribute to the potential increase in Notch activation by Jagged1. Lithium chloride and BIO, both GSK-3 inhibitors, stabilize beta-catenin, a molecule that can enhance the interaction between Jagged1 and Notch. Bay K8644, by acting as an L-type calcium channel agonist, and Forskolin, by raising cAMP levels, both can modulate intracellular signaling in a manner that might augment Jagged1-mediated Notch activation.
Additionally, Anagrelide, which enhances cAMP levels through PDE III inhibition, and Curcumin, known to suppress NF-kB signaling, could further influence the Notch signaling dynamics, potentially facilitating Jagged1's role in Notch receptor activation.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that can modulate the PI3K/Akt pathway, affecting various downstream signaling pathways including Notch, potentially increasing Jagged1-mediated Notch activation. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $46.00 $140.00 $680.00 | 16 | |
PD173074 is an FGFR inhibitor. By inhibiting FGFR signaling, this compound may reduce competitive signaling pathways, potentially allowing for enhanced Notch activation by Jagged1. | ||||||